BioPharma Drug Discovery
Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near ...
October 08, 2024 | News
Thermo Fisher Scientific Launches Accelerator™ Drug Development: Transforming Drug Development with Comprehensive CDMO and CRO Services
Company Launches Accelerator™ Drug Development, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organizatio...
October 07, 2024 | News
ABL Bio Partners with MSD to Evaluate ABL103 and KEYTRUDA® Combo in Advanced Solid Tumor Clinical Trial
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a clinical trial collaboration ...
October 07, 2024 | News
Eisai Expands Direct Presence in Saudi Arabia with New Pharmaceutical Sales Subsidiary
Eisai announced the commencement of full-scale operations at Eisai Pharmaceuticals Single Person Limited Liability Company (Eisai Saudi Arabia), a wholly-o...
October 02, 2024 | News
Akeso's Cadonilimab Gains Approval for First-Line Treatment of Advanced Gastric Cancer in China
Akeso (9926. HK) announced that its internally developed PD-1/CTLA-4 bispecific antibody, cadonilimab, has received approval from the National Medical Prod...
October 01, 2024 | News
Innovent Biologics' New Drug Application for Picankibart Accepted by China's NMPA for Treatment of Moderate to Severe Plaque Psoriasis
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
September 27, 2024 | News
Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients
MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clini...
September 27, 2024 | News
Thermo Fisher Expands North American Oral Drug Development Capabilities with $22M Investment in Cincinnati and Bend Sites
Additions to sites in Cincinnati, Ohio, and Bend, Ore. broaden early development capabilities to help accelerate pre-clinical oral drug product innovation ...
September 27, 2024 | News
Veltassa® Secures Approval in Japan for Hyperkalemia Management in CKD and Heart Failure Patients
Veltassa® offers effective and well-tolerated long-term potassium control in chronic kidney disease and chronic heart failure patients 1-5 Z...
September 25, 2024 | News
XtalPi Launches XFEP and XMolGen to Transform Drug Discovery with AI and Physics-Based Tools
XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug disco...
September 25, 2024 | News
Nuance Pharma Expands Bentrio® Nasal Spray Launch in Asia, Files for Mainland China Approval
Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for ...
September 24, 2024 | News
CD Biopharma Receives FDA Clearance for IND Application of CD-001, Paving the Way for Phase I Clinical Trial
CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application...
September 23, 2024 | News
Henlius Receives Positive CHMP Opinion for HANSIZHUANG (Serplulimab) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer in Europe
Shanghai Henlius Biotech, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued ...
September 23, 2024 | News
Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Sign Master Service Agreement to Advance Novel Drug Discovery
Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as “Axcelead DDP”) announced on September 10 tha...
September 20, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
